258 related articles for article (PubMed ID: 24291862)
1. [Cell replacement therapy for Parkinson's disease using iPS cells].
Takahashi J
Rinsho Shinkeigaku; 2013; 53(11):1009-12. PubMed ID: 24291862
[TBL] [Abstract][Full Text] [Related]
2. [iPS cell therapy for Parkinson's disease].
Takahashi J
Rinsho Ketsueki; 2016 Aug; 57(8):1080-6. PubMed ID: 27599427
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
[TBL] [Abstract][Full Text] [Related]
4. Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.
Sundberg M; Bogetofte H; Lawson T; Jansson J; Smith G; Astradsson A; Moore M; Osborn T; Cooper O; Spealman R; Hallett P; Isacson O
Stem Cells; 2013 Aug; 31(8):1548-62. PubMed ID: 23666606
[TBL] [Abstract][Full Text] [Related]
5. Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy.
Cooper O; Parmar M; Isacson O
Prog Brain Res; 2012; 200():265-76. PubMed ID: 23195423
[TBL] [Abstract][Full Text] [Related]
6. Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease.
Kikuchi T; Morizane A; Doi D; Onoe H; Hayashi T; Kawasaki T; Saiki H; Miyamoto S; Takahashi J
J Parkinsons Dis; 2011; 1(4):395-412. PubMed ID: 23933658
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic Parkinson's disease patient-derived induced pluripotent stem cells function as midbrain dopaminergic neurons in rodent brains.
Kikuchi T; Morizane A; Doi D; Okita K; Nakagawa M; Yamakado H; Inoue H; Takahashi R; Takahashi J
J Neurosci Res; 2017 Sep; 95(9):1829-1837. PubMed ID: 28233934
[TBL] [Abstract][Full Text] [Related]
8. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
Chen W; Huang Q; Ma S; Li M
ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
[TBL] [Abstract][Full Text] [Related]
9. Induced dopaminergic neurons: A new promise for Parkinson's disease.
Xu Z; Chu X; Jiang H; Schilling H; Chen S; Feng J
Redox Biol; 2017 Apr; 11():606-612. PubMed ID: 28110217
[TBL] [Abstract][Full Text] [Related]
10. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.
Pan-Montojo F; Funk RH
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153
[TBL] [Abstract][Full Text] [Related]
11. Cells therapy for Parkinson's disease--so close and so far away.
Ren Z; Zhang Y
Sci China C Life Sci; 2009 Jul; 52(7):610-4. PubMed ID: 19641865
[TBL] [Abstract][Full Text] [Related]
12. Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1.
Samata B; Doi D; Nishimura K; Kikuchi T; Watanabe A; Sakamoto Y; Kakuta J; Ono Y; Takahashi J
Nat Commun; 2016 Oct; 7():13097. PubMed ID: 27739432
[TBL] [Abstract][Full Text] [Related]
13. Co-transplantation of autologous T
Park TY; Jeon J; Lee N; Kim J; Song B; Kim JH; Lee SK; Liu D; Cha Y; Kim M; Leblanc P; Herrington TM; Carter BS; Schweitzer JS; Kim KS
Nature; 2023 Jul; 619(7970):606-615. PubMed ID: 37438521
[TBL] [Abstract][Full Text] [Related]
14. Stem cell potential in Parkinson's disease and molecular factors for the generation of dopamine neurons.
Kim HJ
Biochim Biophys Acta; 2011 Jan; 1812(1):1-11. PubMed ID: 20713152
[TBL] [Abstract][Full Text] [Related]
15. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
Han F; Wang W; Chen B; Chen C; Li S; Lu X; Duan J; Zhang Y; Zhang YA; Guo W; Li G
Cytotherapy; 2015 May; 17(5):665-79. PubMed ID: 25747741
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic differentiation using pluripotent stem cells.
Momčilović O; Montoya-Sack J; Zeng X
J Cell Biochem; 2012 Dec; 113(12):3610-9. PubMed ID: 22807388
[TBL] [Abstract][Full Text] [Related]
17. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.
Kikuchi T; Morizane A; Doi D; Magotani H; Onoe H; Hayashi T; Mizuma H; Takara S; Takahashi R; Inoue H; Morita S; Yamamoto M; Okita K; Nakagawa M; Parmar M; Takahashi J
Nature; 2017 Aug; 548(7669):592-596. PubMed ID: 28858313
[TBL] [Abstract][Full Text] [Related]
18. Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo.
Wakeman DR; Hiller BM; Marmion DJ; McMahon CW; Corbett GT; Mangan KP; Ma J; Little LE; Xie Z; Perez-Rosello T; Guzman JN; Surmeier DJ; Kordower JH
Stem Cell Reports; 2017 Jul; 9(1):149-161. PubMed ID: 28579395
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Human Primary with Human iPS Cell-Derived Dopaminergic Neuron Grafts in the Rat Model for Parkinson's Disease.
Peng SP; Copray S
Stem Cell Rev Rep; 2016 Feb; 12(1):105-20. PubMed ID: 26438376
[TBL] [Abstract][Full Text] [Related]
20. Understanding Parkinson's Disease through the Use of Cell Reprogramming.
Playne R; Connor B
Stem Cell Rev Rep; 2017 Apr; 13(2):151-169. PubMed ID: 28083784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
